Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avecho Biotechnology Ord Shs V.AVE


Primary Symbol: AVEFF

Healthcare
Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.


OTCPK:AVEFF - Post by User

Avecho Biotechnology Ord Shs > Tall of the Tape - FMV of Net Assets 1.02/share
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(17)
•••
Comment by Funinthesun1on Jan 05, 2018 8:24am
130 Views
Post# 27287751

RE:RE:Tall of the Tape - FMV of Net Assets 1.02/share

RE:RE:Tall of the Tape - FMV of Net Assets 1.02/shareYup, should be a run up in no time.  Rumour is this quarter will blow all expectations.  Word is getting out and employees and family members may just be “buying in”.  


Futureisbright wrote: Good post TallerCraig......Hence the big volume today.  Smart folks starting to take positions for the strong share appreciation that is starting to happen.  Like I said in my earlier post, this will be in the 2-3 dollar range in in next 6 months. However, the value will be justified, so I’m not expecting this to go up just to be dumped for quick profit.   Heck, why dump something at $0.80 when you know it is worth more and will get there in short to medium term.  That 500,000 shares today was for a good reason......
cheers......


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities